MorphoSys Receives First Patent on Novel Antibody Platform Ylanthia in the US
- Friday, February 8, 2013, 1:43
- Market Wire
- Add a comment
MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwire – Feb 8, 2013) – MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that the
US Patent and Trademark Office (USPTO) has granted the first patent
covering the
Company’s latest antibody platform Ylanthia, which became commercially
available
for existing and new partners in 2012.
Source: http://www.marketwire.com/mw/release.do?id=1754590&sourceType=3
About the Author
admin has written 21725 stories on this site.